353. O Connor CM, Velazquez EJ, Gardner LH, et al. Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25 year expe- rience from the Duke Cardiovascular Disease Databank). Am J Cardiol. 2002;90:101 7. 354. Phillips HR, O Connor CM, Rogers J. Revascularization for heart failure. Am Heart J. 2007;153:65 73. 355. Tarakji KG, Brunken R, McCarthy PM, et al. Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction. Circulation. 2006;113:230 7. 356. Tsuyuki RT, Shrive FM, Galbraith PD, et al. Revascularization in patients with heart failure. CMAJ. 2006;175:361 5. 357. Deleted in proof. 358. Deleted in proof. 359. Brener SJ, Lytle BW, Casserly IP, et al. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation. 2004;109:2290 5. 360. Hannan EL, Racz MJ, Walford G, et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med. 2005;352:2174 83. 361. Deleted in proof. 362. The BARI Investigators. influence of diabetes on 5 year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascular- ization Investigation (BARI). Circulation. 1997;96:1761 9. 363. The BARI Investigators. The final 10 year follow-up results from the BARI randomized trial. J Am Coll Cardiol. 2007;49:1600 6. 364. Banning AP, Westaby S, Morice MC, et al. Diabetic and nondiabetic patients with left main and/or 3 vessel coronary artery disease: com- parison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol. 2010;55:1067 75. 365. Hoffman SN, TenBrook JA, Wolf MP, et al. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. 